Amanote Research
Register
Sign In
Drug Development and Registration: Challenges and Opportunities in Ovarian Cancer
Cancer
- United States
doi 10.1002/cncr.30645
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
May 12, 2017
Authors
S. Percy Ivy
Elise C. Kohn
Publisher
Wiley
Related search
Opportunities and Challenges of Implementing Pharmacogenomics in Cancer Drug Development
Opportunities and Challenges of the Human Microbiome in Ovarian Cancer
Frontiers in Oncology
Cancer Research
Oncology
Re: Screening for Ovarian Cancer: Imaging Challenges and Opportunities for Improvement
Ultrasound in Obstetrics and Gynecology
Nuclear Medicine
Radiology
Ultrasound Technology
Gynecology
Reproductive Medicine
Radiological
Imaging
Obstetrics
Medicine
Orphan Drug Development in China ‒ Turning Challenges Into Opportunities
Intractable and Rare Diseases Research
Medicine
Cluster Development Models: Challenges and Opportunities
International Journal of Economics, Finance and Management Sciences
Lung Cancer: Future Challenges and Opportunities
Journal of Pulmonary & Respiratory Medicine
Regulatory Considerations on Endpoints in Ovarian Cancer Drug Development
Cancer
Cancer Research
Oncology
Mycobacterial Genomics and Structural Bioinformatics: Opportunities and Challenges in Drug Discovery
Emerging Microbes and Infections
Immunology
Virology
Microbiology
Epidemiology
Parasitology
Medicine
Drug Discovery
Infectious Diseases
Opportunities and Challenges Facing Biomarker Development for Personalized Head and Neck Cancer Treatment
Head and Neck
Otorhinolaryngology
